Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated active pharmaceutical ingredients (APIs) where the nitro group can be reduced to an amine for further functionalization. Its structure supports the introduction of fluorine into bioactive molecules, enhancing metabolic stability and binding affinity. Also employed in agrochemical research for designing novel pesticides and herbicides due to the electron-withdrawing nature of the nitro and fluoro groups, which can influence the compound’s reactivity and biological activity. Suitable for use in cross-coupling reactions and nucleophilic aromatic substitutions in medicinal chemistry workflows.